A cancer patient who crowd-funded his own treatment said the price of drugs to treat the disease is astronomical and we must change the way we decide who receives them.
Mo Haque spoke to talkRADIO after a breast cancer drug named Kadcyla was withdrawn from the NHS in England. The drug, used to treat aggressive breast cancer which is known as HER2 positive, will remain available on the state in Scotland.
Haque was diagnosed with colon cancer in December 2014. After the NHS ran out of treatment options for him, his friend set up a crowdfunding page to raise funds for him to gain private treatment.
Haque told his story to James Max, adding that prices for new cancer drugs are "astronomical".
The interviewee added that we need to change "the way we look at these drugs and who we make them available for."
Haque explained that now he has private treatment, his "quality of life is so much better than it was on chemotherapy" and people are "surprised to hear" he's going through cancer treatment, as he looks so much better.
Listen to the full interview above